You are here

EMMYON, INC.

Company Information
Address
E152 BioVentures Center
CORALVILLE, IA 52241-4710
United States


http://www.emmyon.com

Information

UEI: M8CMYGLPB5H7

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of novel therapeutics for cancer cachexia

    Amount: $990,411.00

    PROJECT SUMMARY / ABSTRACT Cancer-induced skeletal muscle atrophy is a central and defining feature of the cancer cachexia syndrome, a highly prevalent condition that affects over 50% of patients with ...

    SBIRPhase II2023Department of Health and Human Services National Institutes of Health
  2. Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

    Amount: $1,490,808.00

    PROJECT SUMMARY / ABSTRACT Skeletal muscle atrophy diminishes the health and quality of life of tens of millions of people in the US alone. Frequent causes of muscle atrophy (which often co-exist in t ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  3. Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy

    Amount: $1,492,294.00

    PROJECT SUMMARYABSTRACT Skeletal muscle atrophy diminishes the health and quality of life of tens of millions of people in the US aloneFrequent causes of muscle atrophywhich often co exist in the same ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  4. Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

    Amount: $225,000.00

    DESCRIPTION provided by applicant Skeletal muscle atrophy is a highly prevalent condition caused by advanced age muscle disuse chronic illness critical illness and malnutrition In addition to ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  5. Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): Skeletal muscle atrophy is a widespread and serious medical problem. Frequent causes of skeletal muscle atrophy include orthopedic injuries, bed rest, advanced ag ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
  6. Intelligent and Automatic Image Segmentation Software for High ThroughputAnalysi

    Amount: $160,002.00

    DESCRIPTION (provided by applicant): Aging-induced skeletal muscle atrophy, also known as sarcopenia, affects approximately 30 million people in the United States, often leading to weakness, reduced ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government